Assessment of the level of daytime sleepiness in patients with arterial hypertension against polycystic ovarian syndrome

  • Received 16.06.2021

  • Revised 21.07.2021

  • Accepted 30.08.2021



  • 904 Views

  • Retrieved from Volume 3, No. 3, 2021

  • Pages 49-53

Summary. There is a need for a better understanding of sleep disorders in patients with polycystic ovary syndrome (PCOS) combined with hypertension to develop effective care strategies for such patients. The aim of the study – to assess the level of daytime sleepiness in patients with hypertension on the background of polycystic ovary syndrome. Materials and Methods. The study included 54 women with PCOS, aged (38.4±2.3), hypertension was diagnosed in 24 patients (experimental group 1) and 20 patients with normal blood pressure (comparison group). The control group consisted of 10 healthy individuals. ESS-Epworth scale was used to screen for sleep apnea syndrome. Results. In case of hypertension on the background of PCOS the moderate likelihood of drowsiness in the following poses and actions: sitting and reading, watching TV programs, while driving is registered a passenger in the car for 1 hour without a break, lying down, resting, in the afternoon, when circumstances allow, sitting at rest in the afternoon without drinking alcohol. These patients in study group 1 have little chance of drowsiness when they sit (without activity) in a public place, such as during a meeting or in the theater, sitting with someone talking, sitting in the car behind the wheel, stopping for a few minutes. The data obtained in patients of the experimental groups 1 and 2 probably exceed the results obtained in the control group (except for "sitting in the car behind the wheel, stopping for a few minutes" in the comparison group). The data obtained indicate an increase in the level of daytime sleepiness in women with PCOS, in combination with hypertension. Conclusions. The results indicate an increased level of daytime sleepiness, which corresponds to moderate drowsiness, in patients with hypertension on the background of polycystic ovary syndrome, while patients with PCOS without hypertension show only mild daytime sleepiness compared to the normal range of sleepiness in healthy women

sleep disorders, polycystic ovary syndrome, hypertension

https://doi.org/10.11603/bmbr.2706-6290.2021.3.12569

[1] Mokhlesi B, Scoccia B, Mazzone T, Sam S. Risk of obstructive  sleep  apnea  in  obese  and  nonobese  women with polycystic ovary syndrome and healthy reproductively normal women. Fertil Steril. 2012;97(3): 786-91.

[2] Tasali  E,  Van  Cauter  E,  Ehrmann  DA.  Polycystic ovary syndrome and obstructive sleep apnea. Sleep Med Clin. 2008;3: 37-46.

[3] Kumarendran B, O’Reilly MW, Manolopoulos KN, Toulis KA, Gokhale  KM,  Sitch  AJ,  Wijeyaratne  CN,  Coomarasamy  A, Arlt  W,  Nirantharakumar  K.  Polycystic  ovary  syndrome, androgen  excess,  and  the  risk  of  nonalcoholic  fatty liver  disease  in  women:  a  longitudinal  study  based  on  a United  Kingdom  primary  care  database.  PLoS  Medicine. 2018;15(3): DOI:  10.1371/journal.pmed.1002542.

[4] Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK.  Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice  guideline. Journal  of  Clinical  Endocrinology  and Metabolism  2013;98(12):  4565-92,  DOI:  10.1210/jc.2013-2350.

[5] Randeva HS, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar  N,  Lehnert  H.    Cardiometabolic  aspects  of  the polycystic ovary syndrome. Endocrine Reviews. 2012;33(5): 812-41. DOI: 10.1210/er.2012-1003.

[6] Tock L, Carneiro G, Togeiro SM, Hachul H, Pereira AZ,  Tufik S, Zanella MT. Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary  syndrome.  Endocr  Pract.  2014;20(3):  244-51. DOI: 10.4158/EP12366.OR.

[7] Yang  HP,  Kang  JH,  Su  HY,  Tzeng  CR,  Liu  WM, Huang  SY.  Apnea-hypopnea  index  in  nonobese  women with  polycystic  ovary  syndrome.  Int  J  Gynaecol  Obstet 2009;105: 226-9.

[8] Nitsche K, Ehrmann DA. Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2010;24: 717-30.

[9] Williams B, Mancia G,  Spiering W. 2018 ESC/ESH Guidelines  for  the  management  of  arterial  hypertension. European Heart Journal. 2018;39(33): 3021-104.

[10] Kahal H, Kyrou I, Uthman O, Brown A, Johnson S, Wall  P,  Metcalfe  A,  Tahrani  AA,  Randeva  HS.  The association  between  obstructive  sleep  apnoea  and metabolic  abnormalities  in  women  with  polycystic  ovary syndrome: a systematic review and meta-analysis. Sleep. 2018;41: 1-12.

[11] Nitsche K, Ehrmann DA. Obstructive sleep apnea and  metabolic  dysfunction  in  polycystic  ovary  syndrome. Best  Practice  and  Research.  Clinical  Endocrinology  and Metabolism. 2010;24: 717-30.

[12] Kapsimalis F, Kryger MH. Gender and obstructive sleep  apnea  syndrome,  part  2: mechanisms.  Sleep. 2002;25: 499-506.

[13] Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society. 2008;5: 136-43.

[14] Fung  ML.  Pathogenic  roles  of  the  carotid  body inflammation  in  sleep  apnea.  Mediators  of  Inflammation. 2014;2014: 354279.

[15] Behan M, Wenninger JM. Sex steroidal hormones and  respiratory  control.  Respiratory  Physiology  and Neurobiology. 2008;164: 213-21.

[16] O'Malley PM Johnston LD, Bachman JF. Alcohol use among adolescents.  Alcohol Health and Research World. 1998;22: 85-93.

[17] Lee J, Eklund EE, Lambert-Messerlian G, Palomaki GE, Butterfield K, Curran P, Bourjeily G.  Serum progesterone levels in pregnant women with obstructive sleep apnea: a case control study. Journal of Women’s Health. 2017;26: 259-65.  DOI: 10.1089/jwh.2016.5917

[18] Ruchała  M,  Bromińska  B,  Cyrańska-Chyrek  E, Kuźnar-Kamińska  B,  Kostrzewska  M,  Batura-Gabryel  H. Obstructive sleep apnea and hormones – a novel insight. Archives of Medical Science. 2017;13: 875-84.